Parkinsons disease therapy (Arena)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameParkinsons disease therapy (Arena)
Drug Alias Name19X GPCR antagonists (Arena)AR-139525
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsNerve DegenerationParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArena Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A